CIWA-B
Also written as: CIWA-B — Clinical Institute Withdrawal Assessment for Benzodiazepines
Clinical Institute Withdrawal Assessment for Benzodiazepines, a standardized tool for monitoring benzodiazepine withdrawal symptoms.
Full Definition
The CIWA-B (Clinical Institute Withdrawal Assessment for Benzodiazepines) is a validated assessment instrument used to monitor and quantify the severity of benzodiazepine withdrawal symptoms. This tool evaluates symptoms including anxiety, tremor, sweating, nausea, headache, agitation, and sensory disturbances. Healthcare providers use CIWA-B scores to guide medication protocols, determine the need for medical intervention, and track withdrawal progress. Unlike the more commonly known CIWA-Ar for alcohol withdrawal, CIWA-B is specifically designed for the unique presentation of benzodiazepine discontinuation syndrome.
Usage
Usage note: Always include the '-B' suffix to distinguish from CIWA-Ar (alcohol withdrawal assessment).
In Context
- "The nurse completed a CIWA-B assessment every eight hours during the client's benzodiazepine taper." — Medical record
- "Elevated CIWA-B scores indicated the need for slower medication reduction and additional comfort measures." — Treatment planning note